DVFFR is a coronary blood flow reserve fraction calculation software developed by Keya Medical. It is the first product in my country to obtain the Class III certificate for artificial intelligence medical devices from NMPA. It is an intelligent and non-invasive CTFFR product. Its first certification is not only a new starting point for smart medical care in my country, but also a milestone for AI device review.
So it is not difficult to see that DVFFR is a product, while CTFFR is a diagnostic method for coronary heart disease.
In addition, DVFFR, as the first smart product in China equipped with CTFFR technology, is also the first product in the world to use deep learning technology to assess coronary artery physiological function. The DVFFR system only needs the tester's coronary CTA image to efficiently and accurately calculate the FFR value of each point on the entire blood vessel tree, quickly provide clinically required quantitative detection results, assist doctors in selecting treatment plans and routes, and truly realize the treatment of coronary heart disease. Non-invasive testing.
The clinical application of DVFFR has promoted the development of CTFFR technology in China at a macro level, providing doctors with efficient diagnostic tools, saving medical resources, reducing the amount of surgeries and over-treatment; saving money for the country A large amount of medical insurance funds promote the healthy, stable and sustainable operation of the social medical insurance system. In a practical sense, it reduces the extra radiation caused by unnecessary coronary angiography for patients, reduces the possible risks of contrast agent allergy and other complications during the operation, and reduces the economic burden on patients.